MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202341087502 A) filed by Tata Institute For Genetics And Society; and Bruhat Bengaluru Mahanagar Palike, Bangalore, Karnataka, on Dec. 21, 2023, for 'duplex quantitative molecular assay for simultaneous detection of hepatitis b and hepatitis c viruses.'
Inventor(s) include Mansi Rajendra Malik.
The application for the patent was published on June 27, under issue no. 26/2025.
According to the abstract released by the Intellectual Property India: "The present invention discloses methods and compositions for fluorescence-based quantitative detection assay and kit for Hepatitis B and Hepatitis C causing viral infections simultaneously using a single reaction mix. The current invention more particularly relates to compositions and methods for qualitative and quantitative detection of Hepatitis B and Hepatitis C causing viruses based on Duplex quantitative nucleic acid based molecular assay, using primer sets and fluorophore tagged probe sequences."
Disclaimer: Curated by HT Syndication.
